AxoGen Stock News & Updates

[WKN: A1JMHK | Symbol: AXGN]

AxoGen: FDA Approval and Growth Acceleration Impress!

AxoGen (AXGN) is one of my top breakout candidates among the medical technology stocks. The company provides...

AxoGen receives dual analyst support after FDA approval with targets up to $40 (+40 %)

The stock of AxoGen (AXGN) was recently discussed when it broke out to a new multi-year high. The company...

TOP-5 Price Targets from Analysts on 01.12.25

Microbot Medical [US59503A2042] H.C. Wainwright reiterates Buy rating with a price target of $12...

Axogen: The Pioneer in the Regeneration of Peripheral Nerves

Axogen is a leader in the development of surgical solutions for the repair of peripheral nerves. The...

Analysts' Top 5 Price Targets of October 30, 2025

A xoGen [US05463X1063] Citizens JMP reaffirms Buy rating and raises the price target from $26...

Analysts' Top 5 Price Targets of July 24, 2025

AxoGen Inc. [US05463X1063] Lake Street reaffirms Buy rating with a price target of $30 (123% upside...

Analysts' Top 5 Price Targets of May 17, 2025

Norwegian Cruise Line [BMG667211046]: JPMorgan upgrades from Neutral to Overweight with an unchanged...

NEO-DARVAS STRATEGY: Pitney Bowes, Madrigal Pharmaceuticals, AxoGen, Turning Point Brands

Pitney Bowes Pitney Bowes (NYSE: PBI) is a shipping and postal company that provides logistics, technology,...

Analysts' Top 5 Price Targets of March 5, 2025

AxoGen [US05463X1063]: JMP Securities reaffirms Buy rating and raises the price target from $20 to $26...

  • 1